# OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
> **ANDA210718** · Abbreviated New Drug Application (Generic) · Sponsor: PIRAMAL · Approved 2025-05-14
## Drug
- **FDA Application Number:** ANDA210718
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
- **Generic name:** OLMESARTAN MEDOXOMIL AND AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE
- **Active ingredients:** AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PIRAMAL
- **Manufacturer:** Slate Run Pharmaceuticals, LLC
- **First approval:** 2025-05-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210718)
---
*AI Analytics · CC0 1.0*